FAST NEWS: Wuxi Bio’s Subsidiary Removed from U.S. ‘Unverified’ List
The latest: Contract drug services provider WuXi Biologics (Cayman) Inc. (2269.HK) announced on Monday its WuXi Biologics Co. Ltd. subsidiary has been removed from the “unverified” list maintained by the U.S. Commerce Department, following…
RELATED ARTICLES
-
Potential U.S. targeting casts shadow over WuXi AppTec family
2359.HK 603259.SHG -
WuXi Bio prescribes share buyback to relieve revenue pain
2269.HK
-
FAST NEWS: WuXi Biologics boosts new projects target
2269.HK
-
FAST NEWS: WuXi XDC kicks off IPO with star cornerstone investors
2269.HK
- CHINA BULLETIN: Local Governments Crushed by Debt
